Deubiquitination of SARM1 by USP13 regulates SARM1 activation and axon degeneration

IF 6 Life medicine Pub Date : 2023-11-04 DOI:10.1093/lifemedi/lnad040
Wenkai Yue, Kai Zhang, Mingsheng Jiang, Wenjing Long, Jihong Cui, Yunxia Li, Yaoyang Zhang, Ang Li, Yanshan Fang
{"title":"Deubiquitination of SARM1 by USP13 regulates SARM1 activation and axon degeneration","authors":"Wenkai Yue, Kai Zhang, Mingsheng Jiang, Wenjing Long, Jihong Cui, Yunxia Li, Yaoyang Zhang, Ang Li, Yanshan Fang","doi":"10.1093/lifemedi/lnad040","DOIUrl":null,"url":null,"abstract":"Abstract Sterile alpha and Toll/interleukin 1 receptor motif-containing protein 1 (SARM1) is regarded as a key protein and a central executor of the self-destruction of injured axons. To identify novel molecular players and understand the mechanisms regulating SARM1 function, we investigated the interactome of SARM1 by proximity-labeling and proteomic profiling. Among the SARM1-assoicated proteins, we uncovered that overexpression (OE) of ubiquitin-specific peptidase 13 (USP13) delayed injury-induced axon degeneration. OE of an enzyme-dead USP13 failed to protect injured axons, indicating that the deubiquitinase activity of USP13 was required for its axonal protective effect. Further investigation revealed that USP13 deubiquitinated SARM1, which increased the inhibitory interaction between the N-terminal armadillo repeat motif (ARM) and C-terminal Toll/interleukin-1 receptor (TIR) domains of the SARM1 protein, thereby suppressing SARM1 activation in axon injury. Collectively, these findings suggest that increase of USP13 activity enhances the self-inhibition of SARM1, which may provide a strategy to mitigate axon degeneration in injury and disease.","PeriodicalId":74073,"journal":{"name":"Life medicine","volume":"54 5","pages":"0"},"PeriodicalIF":6.0000,"publicationDate":"2023-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Life medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/lifemedi/lnad040","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract Sterile alpha and Toll/interleukin 1 receptor motif-containing protein 1 (SARM1) is regarded as a key protein and a central executor of the self-destruction of injured axons. To identify novel molecular players and understand the mechanisms regulating SARM1 function, we investigated the interactome of SARM1 by proximity-labeling and proteomic profiling. Among the SARM1-assoicated proteins, we uncovered that overexpression (OE) of ubiquitin-specific peptidase 13 (USP13) delayed injury-induced axon degeneration. OE of an enzyme-dead USP13 failed to protect injured axons, indicating that the deubiquitinase activity of USP13 was required for its axonal protective effect. Further investigation revealed that USP13 deubiquitinated SARM1, which increased the inhibitory interaction between the N-terminal armadillo repeat motif (ARM) and C-terminal Toll/interleukin-1 receptor (TIR) domains of the SARM1 protein, thereby suppressing SARM1 activation in axon injury. Collectively, these findings suggest that increase of USP13 activity enhances the self-inhibition of SARM1, which may provide a strategy to mitigate axon degeneration in injury and disease.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
USP13介导的SARM1去泛素化调控SARM1的激活和轴突退化
无菌α和Toll/白细胞介素1受体基序-含蛋白1 (SARM1)被认为是受损轴突自我破坏的关键蛋白和中心执行蛋白。为了确定新的分子参与者并了解调节SARM1功能的机制,我们通过接近标记和蛋白质组学分析研究了SARM1的相互作用组。在sarm1相关蛋白中,我们发现泛素特异性肽酶13 (USP13)的过表达(OE)延迟了损伤诱导的轴突变性。酶死亡的USP13的OE不能保护受损的轴突,这表明USP13的去泛素酶活性是其轴突保护作用的必要条件。进一步研究发现,USP13使SARM1去泛素化,增加了SARM1蛋白n端armillo repeat motif (ARM)和c端Toll/白细胞介素-1受体(TIR)结构域之间的抑制相互作用,从而抑制SARM1在轴突损伤中的激活。总的来说,这些发现表明USP13活性的增加增强了SARM1的自我抑制,这可能为减轻损伤和疾病中的轴突退化提供了一种策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
New paradigm for aging research: aging studies through innovative AI applications and interdisciplinary collaborations. Liver regeneration: cytokine regulation targeting hepatocytes and beyond. Integration of a novel anti-PD-1 antibody with chimeric antigen receptor-T engineered to express interleukin-7 enhances targeting efficacy against lung cancer. Genetically engineered senescence-resistant human mesenchymal progenitor cells promote spinal cord injury repair. Senescent B cells regulate CD38 expression via FOXO1 in pneumonia resulting from PIK3CD (R437C) mutations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1